rasagiline has been researched along with Sleep Wake Disorders in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandt, MD; Brown, S; Fauser, M; Graehlert, X; Löhle, M; Maaß, A; Ossig, C; Otto, K; Reichmann, H; Schrempf, W; Schwanebeck, U; Storch, A; Wienecke, M | 1 |
| Liguori, C; Mercuri, NB; Pierantozzi, M; Ruffini, R; Stefani, A | 1 |
| Bélanger, M; Chouinard, S; Coffin, D; Lehoux, G; Panisset, M; Stril, JL | 1 |
| Tarrants, ML; Zagmutt, FJ | 1 |
| Blin, O; Lancrenon, S; Pitel, S; Viallet, F | 1 |
| Schapira, AH | 1 |
2 review(s) available for rasagiline and Sleep Wake Disorders
| Article | Year |
|---|---|
Indirect comparisons of adverse events and dropout rates in early Parkinson's disease trials of pramipexole, ropinirole, and rasagiline.
Topics: Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Cross-Sectional Studies; Databases, Bibliographic; Fatigue; Female; Gastrointestinal Diseases; Humans; Indans; Indoles; Logistic Models; Male; Parkinson Disease; Patient Dropouts; Pramipexole; Sleep Wake Disorders; Treatment Outcome | 2012 |
Present and future drug treatment for Parkinson's disease.
Topics: Benzothiazoles; Corpus Striatum; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Humans; Indans; Indoles; Levodopa; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Pramipexole; Psychomotor Performance; Sexual Dysfunction, Physiological; Sleep Wake Disorders; Substantia Nigra; Thiazoles; Urinary Incontinence | 2005 |
2 trial(s) available for rasagiline and Sleep Wake Disorders
| Article | Year |
|---|---|
Rasagiline improves polysomnographic sleep parameters in patients with Parkinson's disease: a double-blind, baseline-controlled trial.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Indans; Male; Middle Aged; Neuroprotective Agents; Parkinson Disease; Polysomnography; Sleep; Sleep Wake Disorders; Treatment Outcome | 2018 |
Evaluation of the safety and tolerability of rasagiline in the treatment of the early stages of Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Indans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Parkinson Disease; Pramipexole; Sleep Wake Disorders; Time Factors | 2013 |
2 other study(ies) available for rasagiline and Sleep Wake Disorders
| Article | Year |
|---|---|
Safinamide effect on sleep disturbances and daytime sleepiness in motor fluctuating Parkinson's disease patients: A validated questionnaires-controlled study.
Topics: Aged; Alanine; Antiparkinson Agents; Benzylamines; Female; Humans; Indans; Male; Middle Aged; Parkinson Disease; Sleep; Sleep Wake Disorders; Surveys and Questionnaires | 2018 |
Open-Label Study of Sleep Disturbances in Patients with Parkinson's Disease Treated with Rasagiline.
Topics: Aged; Dose-Response Relationship, Drug; Female; Humans; Indans; Male; Middle Aged; Neuroprotective Agents; Parkinson Disease; Psychiatric Status Rating Scales; Retrospective Studies; Severity of Illness Index; Sleep Wake Disorders; Treatment Outcome | 2016 |